The FDA-approved Rapid Covid-19 Test kits provide results in five minutes. Credit: Molecule Holdings.

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Follow the latest updates of the outbreak on our timeline.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Molecule Holdings has launched its coronavirus (Covid-19) diagnosis test kits for immediate distribution to medical professionals, following its emergency use authorisation (EUA) by the US Food and Drug Administration (FDA).

The Covid Care Rapid test detects IgG and IgM antibodies to SARS-CoV-2 in human blood and delivers results in five minutes. It is said to have a 91% clinical sensitivity rating and a 99% clinical specificity rating.

Furthermore, the test offers affordable, point-of-care testing compared to PCR technology-based coronavirus tests, which take multiple days to show results.

The Covid Care Rapid test was developed by Pinnacle BioLabs. It is manufactured in ISO -13485 certified facility.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Prior to the launch, the test has undergone significant preliminary clinical testing and can provide diagnostic specificity higher than 90%.

The test kit contains a lancet to prick the finger and testing cassette to place blood drops. It also comes with a testing solution, which has to be mixed with the obtained blood to get the result.

The testing process is similar to the tests used by diabetics to test their blood sugar.

Molecule Holdings will soon provide the test kits to medical professionals, first responders and law enforcement.

Meanwhile, medical companies and laboratories across the US are striving to develop and produce more Covid-19 detection tests to meet the increasing demand.

Recently, FDA granted EUA to several companies, including Bodysphere, Luminex, and Abbott for their Covid-19 detection tests.

According to the latest reports, there are more than 216,721 confirmed coronavirus cases and 5,138 deaths in the US.